sham IMTIMT-stable group (sitting on a stable surface)IMT-unstable group (sitting on an unstable surface)Conventional treatment
sham IMT: with 10% maximum inspiratory pressure (MIP) as the training intensity, IMT will be conducted on a stable surface
IMT-stable group (sitting on a stable surface): 50% MIP as the training intensity, IMT will be conducted while sitting on a stable surface
IMT-unstable group (sitting on an unstable surface): 50% MIP as the training intensity, IMT will be conducted while sitting on an unstable surface
Conventional treatment: Participants in all groups will receive a standardised conventional rehabilitation protocol. It includes limb range of motion, muscle tone reduction, strengthening and endurance of limb muscles, transfer skills, task-directed movements, general gait training, and activities of daily living training.
Study summary
This study is designed to explore the effects of a 4-week protocol of inspiratory muscle training (IMT) at 50% maximum inspiratory pressure (MIP) on respiratory function, diaphragm thickness, balance control, exercise capacity, and quality of life in people after stroke. To ascertain the effect of IMT on the relationship between diaphragm muscle contraction and activation of other trunk muscles, this study also explores whether any effect of the 4-week IMT protocol on balance control is associated with changes in the anticipatory posture adjustments (APAs) time - the onset time of postural muscles during a required task (e.g., the rapid shoulder flexion test).
Eligibility
Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Age ≥ 40 years and \< 80 years;
* breathing spontaneously;
* clinically diagnosed with ischemic and/or haemorrhagic stroke;
* duration of stroke from onset falls within 1 month to 12 months after diagnosis;
* no thoracic or abdominal surgery within the last 6 months;
* able to understand and follow verbal instructions;
* no facial palsy, or mild facial palsy without limitation of labial occlusion;
* able to maintain a resting sitting posture without feet support for at least 30 seconds;
* no cognitive impairment (Montreal Cognitive Assessment (MoCA) score ≥ 26);
* able to independently walk at least 10 meters with or without an assistive device.
Exclusion Criteria:
* acute myocardial infarction or acute heart failure;
* acute pain in any part of the body;
* with respiratory illness or positive clinical signs of impaired respiratory function (such as shortness of breath, hypoxemia, chronic cough and sputum retention);
* with chronic cardiovascular dysfunction;
* Trunk Impairment Scale (TIS) score ≥ 20.
* patient with a nasal feeding tube, tracheal tube and/or any condition that prevents the measurement or the implementation of the study procedure.
Primary outcome measure(s)
Diaphragmatic thickness — baseline, after 4 weeks of intervention The diaphragmatic thickness of both the left and right diaphragms will be measured by ultrasound. (Mindray M9, Shenzhen, China).
Trial sites (1)
Facility
City
Region
Status
Shenzhen Second People's Hospital
Shenzhen
None Selected
Recruiting
More Hong Kong Metropolitan University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.